JP4907750B2 - サトウキビ・ワックスから得られる第一級脂肪酸の混合物 - Google Patents

サトウキビ・ワックスから得られる第一級脂肪酸の混合物 Download PDF

Info

Publication number
JP4907750B2
JP4907750B2 JP54135598A JP54135598A JP4907750B2 JP 4907750 B2 JP4907750 B2 JP 4907750B2 JP 54135598 A JP54135598 A JP 54135598A JP 54135598 A JP54135598 A JP 54135598A JP 4907750 B2 JP4907750 B2 JP 4907750B2
Authority
JP
Japan
Prior art keywords
weight
acid
mixture
amount
total weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP54135598A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001518092A5 (enExample
JP2001518092A (ja
Inventor
ゴンザレス・ブラボ，ルイ
マレーロ・デランヘ，ダビード
ラグーナ・グランハ，アビリオ
マス・フェレイロ，ロサ・マリア
デ・ロウルデス・アルササバラ・バルマーニャ，マリア
カルバハル・キンターナ，ダイシ
コラ・メディーナ，ミリアン
メネンデス・ソト・デル・バジェ，ロベルト
Original Assignee
ラボラトリオス・ダルメル・エセ・アー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ラボラトリオス・ダルメル・エセ・アー filed Critical ラボラトリオス・ダルメル・エセ・アー
Publication of JP2001518092A publication Critical patent/JP2001518092A/ja
Publication of JP2001518092A5 publication Critical patent/JP2001518092A5/ja
Application granted granted Critical
Publication of JP4907750B2 publication Critical patent/JP4907750B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
JP54135598A 1997-04-02 1998-04-01 サトウキビ・ワックスから得られる第一級脂肪酸の混合物 Expired - Lifetime JP4907750B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU1997035A CU22723A1 (es) 1997-04-02 1997-04-02 Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos
CU35/97 1997-04-02
PCT/IB1998/000870 WO1998043631A1 (en) 1997-04-02 1998-04-01 Mixture of primary fatty acids obtained from sugar cane wax

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011250436A Division JP2012067119A (ja) 1997-04-02 2011-11-16 サトウキビ・ワックスから得られる第一級脂肪酸の混合物

Publications (3)

Publication Number Publication Date
JP2001518092A JP2001518092A (ja) 2001-10-09
JP2001518092A5 JP2001518092A5 (enExample) 2005-10-06
JP4907750B2 true JP4907750B2 (ja) 2012-04-04

Family

ID=5459247

Family Applications (2)

Application Number Title Priority Date Filing Date
JP54135598A Expired - Lifetime JP4907750B2 (ja) 1997-04-02 1998-04-01 サトウキビ・ワックスから得られる第一級脂肪酸の混合物
JP2011250436A Pending JP2012067119A (ja) 1997-04-02 2011-11-16 サトウキビ・ワックスから得られる第一級脂肪酸の混合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011250436A Pending JP2012067119A (ja) 1997-04-02 2011-11-16 サトウキビ・ワックスから得られる第一級脂肪酸の混合物

Country Status (19)

Country Link
US (1) US6486205B2 (enExample)
EP (1) EP0969827B1 (enExample)
JP (2) JP4907750B2 (enExample)
CN (1) CN1230158C (enExample)
AR (1) AR016054A1 (enExample)
AT (1) ATE233087T1 (enExample)
AU (1) AU732045B2 (enExample)
BR (1) BR9808470A (enExample)
CA (1) CA2285242C (enExample)
CO (1) CO4940484A1 (enExample)
CU (1) CU22723A1 (enExample)
DE (1) DE69811643T2 (enExample)
DK (1) DK0969827T3 (enExample)
ES (1) ES2192769T3 (enExample)
MY (1) MY120318A (enExample)
PT (1) PT969827E (enExample)
RU (1) RU2217130C2 (enExample)
WO (1) WO1998043631A1 (enExample)
ZA (1) ZA982744B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4666705B2 (ja) * 1999-12-07 2011-04-06 三井製糖株式会社 消化管潰瘍予防剤または改善剤
US20030203854A1 (en) * 2002-04-23 2003-10-30 Ivo Pischel Composition for effecting serum cholesterol levels
PT1515714E (pt) * 2002-06-17 2009-10-06 Medestea Res & Production S P Compostos oxigenados insaturados de cadeia longa e sua utilização no campo terapêutico, cosmético e nutracêutico
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
US20060013842A1 (en) * 2004-07-15 2006-01-19 Matkin John R Natural mixture of long-chain fatty alcohols and long-chain fatty acids, its obtension from animal and vegetable waxes and its nutraceutical uses
US7542034B2 (en) * 2004-09-23 2009-06-02 Conversion Works, Inc. System and method for processing video images
KR100723950B1 (ko) * 2005-01-04 2007-05-31 주식회사 하이폭시 벼과 식물 추출물을 포함하는 허혈성 질환 및 퇴행성뇌질환의 예방 및 치료를 위한 조성물
KR100685681B1 (ko) * 2005-07-26 2007-02-26 전북대학교산학협력단 수수에서 폴리코사놀 또는 옥타코사놀 함량이 높은긴사슬지방을 제조하는 방법
TW200730518A (en) * 2005-10-12 2007-08-16 Sicor Inc Crystalline forms of docetaxel and processes for their preparation
US20070295326A1 (en) * 2006-06-07 2007-12-27 Rafael Almagro Method for obtaining long chain aliphatic alcohols and fatty acids from sugar cane mud and related wax esters
US20080207748A1 (en) * 2007-02-22 2008-08-28 Innovation Labs, Inc. Vitamin c preparation
DE102010052789A1 (de) * 2010-11-27 2012-05-31 Wachs-Chemie Elsteraue E.K. Herstellung und Reinigung von PC-Wachs und deren technische Anwendungen
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
KR102429853B1 (ko) * 2017-11-30 2022-08-05 (주)아모레퍼시픽 천연 왁스를 이용한 지방산 조성물 제조방법 및 그에 따라 제조된 지방산 조성물
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
IT201900007329A1 (it) * 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
CU24638B1 (es) * 2020-02-03 2023-01-16 Centro Nac De Investigaciones Cientificas Suspensión oral con efecto antiulceroso y quimioprotector sobre el cáncer de colon
CU24732B1 (es) * 2021-07-13 2025-02-07 Centro Nac De Investigaciones Cientificas Mezcla de compuestos con altos pesos moleculares, obtenida a partir de la cera de caña de azúcar (saccharum officinarum l.)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5160207A (en) * 1974-11-22 1976-05-26 Dai Ichi Kogyo Seiyaku Co Ltd Shibosanto kokyuarukooruno bunriho
JPH0610146B2 (ja) * 1985-10-12 1994-02-09 住友精化株式会社 直鎖第１級脂肪族高級アルコ−ルの抽出法
CA2044162A1 (fr) * 1989-10-13 1991-04-14 Jacques Borg Derives des alcools gras a longue chaine, leurs applications, notamment en tant que molecules cytotrophes et cytoprotectrices, et compositions pharmaceutiques les contenant
CU22225A1 (es) * 1990-11-30 1995-01-31 Cent Nac Investig Scient Composicion farmacautica que contiene mezcla de alcoholes alifaticos primarios superiores para el tratamiento de hipercolesterolemia y la hiperlipoproteinemia tipo ii asi como estimulante de la conducta sexual en animales y humanos
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
JPH06122892A (ja) * 1992-10-09 1994-05-06 Nippon Petrochem Co Ltd 粗ワックスの製造方法
CU22412A1 (es) * 1993-11-09 1996-01-31 Dalmer Lab Sa Una mezcla natural compuesta por alcoholes alifaticos primarios superiores obtenidos de la cera de abejas para el tratamiento de las ulceras gastricas y duodenales que presenta tambien actividad antiinflamatoria
US5554379A (en) * 1994-06-20 1996-09-10 Kv Pharmaceutical Company Long acting GI and esophageal protectant
JP2804445B2 (ja) * 1994-11-30 1998-09-24 ラボラトリオス ダルマー ソシエダッド アノニマ 胃潰瘍および十二指腸潰瘍の処置剤および抗炎症剤
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
AUPO605097A0 (en) * 1997-04-07 1997-05-01 James Cook University Of North Queensland Food grade wax and process for preparing same

Also Published As

Publication number Publication date
AU732045B2 (en) 2001-04-12
RU2217130C2 (ru) 2003-11-27
JP2012067119A (ja) 2012-04-05
EP0969827A1 (en) 2000-01-12
WO1998043631A1 (en) 1998-10-08
CN1258218A (zh) 2000-06-28
MY120318A (en) 2005-10-31
PT969827E (pt) 2003-07-31
BR9808470A (pt) 2000-05-23
ES2192769T3 (es) 2003-10-16
CU22723A1 (es) 2002-02-28
US20020058705A1 (en) 2002-05-16
CA2285242C (en) 2008-12-16
CO4940484A1 (es) 2000-07-24
HK1029054A1 (en) 2001-03-23
ATE233087T1 (de) 2003-03-15
ZA982744B (en) 1998-10-08
JP2001518092A (ja) 2001-10-09
CA2285242A1 (en) 1998-10-08
DE69811643D1 (de) 2003-04-03
CN1230158C (zh) 2005-12-07
DE69811643T2 (de) 2003-12-24
AU7349498A (en) 1998-10-22
EP0969827B1 (en) 2003-02-26
US6486205B2 (en) 2002-11-26
DK0969827T3 (da) 2003-06-16
AR016054A1 (es) 2001-06-20

Similar Documents

Publication Publication Date Title
JP2012067119A (ja) サトウキビ・ワックスから得られる第一級脂肪酸の混合物
KR100269844B1 (ko) 고위 1가 지방산 알코올의 혼합물, 자당납에서 이의 수득방법과 이의 제약학적 용도
DE69931640T2 (de) Verwendung von acetylcholinesterasen hemmern zur herstellung eines arzneimittels zur behandlung von funktionellen und/oder organischen schmerzsyndromen
DE2822727A1 (de) Therapeutisches mittel gegen geschwuere des verdauungstraktes
US6235795B1 (en) Natural mixture composed of higher primary aliphatic alcohols obtained from bee wax for the treatment of gastric and duodenal ulcers that also present antiinflamatory activity
RU99123062A (ru) Смесь первичных жирных кислот, получаемых из сахарно-тросникового воска
JPH0840981A (ja) エイコサペンタエノイルグリセライド
US6465526B1 (en) Natural mixture composed of higher primary aliphatic alcohols obtained from bee wax for the treatment of gastric and duodenal ulcers that also present antiinflamatory activity
JP2804445B2 (ja) 胃潰瘍および十二指腸潰瘍の処置剤および抗炎症剤
JP3623247B2 (ja) 茶葉サポニン類を含む薬剤
JPH0753393A (ja) 動脈硬化抑制剤及びこれを含む食品又は医薬
JPH0680582A (ja) 脂質代謝改善剤
JPH05246857A (ja) 痴呆症治療剤
HK1029054B (en) Mixture of primary fatty acids obtained from sugar cane wax
WO1985005623A1 (fr) Agent de traitement de l'arteriosclerose
DE3308004A1 (de) Verwendung von dibenzocycloheptenyliden-verbindungen zur modulation der immunreaktion
JP3512118B2 (ja) 血中脂質改善剤
JPH07188039A (ja) 抗ガストリン剤およびサブスタンスｐ拮抗剤
JPH0822817B2 (ja) エイコサペンタエノイルグリセライド含有脂質低下剤
JP2024525717A (ja) シュガーケンワックス（ＳＵＧＡＲＣＡＮＥ ＷＡＸ）（サトウキビ：Ｓａｃｃｈａｒｕｍ ｏｆｆｉｃｉｎａｒｕｍ Ｌ．）から得られる高分子量化合物の混合物
JPH06211661A (ja) 抗炎症剤
LU82448A1 (fr) Esters de 2-(6-methoxy-2-naphtyl)-1-propanol,leur procede de preparation et leur application en therapeutique
SE455421B (sv) Monosubstituerade 4-fenyl-4-oxo-2-butensyraderivat till anvendning som lekemedel, anvendning av dessa for framstellning av lekemedel for behandling av magakommor och gastroduodenala akommor i samband med hyperaciditet s
AU2005205164A1 (en) Novel compositions comprising higher primary alcohols and nicotinic acid and process of preparation thereof
JPS6127919A (ja) 利胆剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050215

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050215

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081202

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090227

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090413

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090401

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091027

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100115

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100222

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100217

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100329

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100817

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110117

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20110210

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110517

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110815

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110818

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110913

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110916

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20111005

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20111020

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111116

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111220

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120112

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150120

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term